诺辉健康(06606)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06606 诺辉健康

交易中 03-28 10:32:43

28.900

-1.850

-6.02%

最高31.600	最低28.400	成交量176.55万
今开31.600	昨收30.750	日振幅10.41%
总市值132.23亿	流通市值132.23亿	总股本4.58亿
成交额5,149万	换手率0.39%	流通股本4.58亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06606","market":"HK","secType":"STK","nameCN":"诺辉健康","latestPrice":28.9,"timestamp":1679970713892,"preClose":30.75,"halted":0,"volume":1765500,"delay":0,"floatShares":457544936,"shares":457544936,"eps":-0.21376745,"marketStatus":"交易中","marketStatusCode":2,"change":-1.85,"latestTime":"03-28 10:32:43","open":31.6,"high":31.6,"low":28.4,"amount":51488250,"amplitude":0.104065,"askPrice":28.95,"askSize":11000,"bidPrice":28.9,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.21678533020386057,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1679976000000},"adr":0,"listingDate":1613577600000,"adjPreClose":30.75,"volumeRatio":4.11817,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06606","defaultTab":"news","newsList":[{"id":"2322493055","title":"南向资金3月24日净买入诺辉健康18.70万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2322493055","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2322493055?lang=zh_CN&edition=full","pubTime":"2023-03-27 09:32","pubTimestamp":1679880735,"startTime":"0","endTime":"0","summary":"3月24日, 南向资金增持诺辉健康18.70万股，连续3日增持。截止当日收盘，港股通共持有诺辉健康7453.54万股，占流通股16.28%。诺辉健康近5个交易日下跌7.81%，港股通累计增持317.40万股；近20个交易日上涨4.33%，港股通累计增持858.83万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303270937268356d0ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303270937268356d0ae&s=b","is_publish_highlight":false},{"id":"2321885166","title":"诺辉健康与医思健康达成战略合作，共同推动宫证清在港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2321885166","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2321885166?lang=zh_CN&edition=full","pubTime":"2023-03-24 13:47","pubTimestamp":1679636876,"startTime":"0","endTime":"0","summary":"诺辉健康 与 医思健康 签约，达成独家战略合作，未来将全面整合双方的优质资源，共同推动宫证清TM在中国香港的注册上市、分销及市场推广，以居家早筛助力宫颈癌预防医学服务的普及，加速实现宫颈癌的有效预防。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023032414003182701601&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023032414003182701601&s=b","is_publish_highlight":false},{"id":"2321293994","title":"诺辉健康(06606)国内癌症早筛领域领军者","url":"https://stock-news.laohu8.com/highlight/detail?id=2321293994","media":"申万宏源","top":-1,"share":"https://www.laohu8.com/m/news/2321293994?lang=zh_CN&edition=full","pubTime":"2023-03-22 14:15","pubTimestamp":1679465748,"startTime":"0","endTime":"0","summary":"诺辉健康是国内首家专注于开发和商业化癌症筛查产品的生物科技公司。国内癌症早筛市场前景广阔。根据弗若斯特沙利文的分析，2022年中国结直肠癌、胃癌、宫颈癌筛查市场的规模分别为46亿元、37亿元和31亿元。2022年常卫清和噗噗管销售快速放量，收入分别为3.6亿元和2.0亿元，分别同比增长266%和74%。2022年11月，宫证清完成首例患者入组，正式进入注册临床阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230322143035841ca832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230322143035841ca832&s=b","is_publish_highlight":false},{"id":"1170333750","title":"港股生物医药股跌幅扩大，云顶新耀-B跌超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170333750","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1170333750?lang=zh_CN&edition=full","pubTime":"2023-03-20 10:06","pubTimestamp":1679277991,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true},{"id":"2320575510","title":"快讯：生物医药股集体下跌 云顶新耀跌12%诺辉健康跌近9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2320575510","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2320575510?lang=zh_CN&edition=full","pubTime":"2023-03-20 09:58","pubTimestamp":1679277522,"startTime":"0","endTime":"0","summary":"3月20日消息，生物医药股集体下跌，云顶新耀跌12%，诺辉健康跌近9%，开拓药业跌近7%，启明医药、华领医药跌超6%。\n\n\n炒股开户享福利，送投顾服务60天体验权，一对一指导服务！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-03-20/doc-imymnnse3467882.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-03-20/doc-imymnnse3467882.shtml","is_publish_highlight":false},{"id":"2320578439","title":"诺辉健康3月17日遭南向资金减持127.77万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2320578439","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2320578439?lang=zh_CN&edition=full","pubTime":"2023-03-20 09:32","pubTimestamp":1679275932,"startTime":"0","endTime":"0","summary":"3月17日，南向资金减持诺辉健康127.77万股。截止当日收盘，港股通共持有诺辉健康7136.14万股，占流通股15.59%。诺辉健康近5个交易日上涨4.95%，港股通累计减持3.62万股；近20个交易日上涨4.78%，港股通累计增持468.98万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303200937588061d264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303200937588061d264&s=b","is_publish_highlight":false},{"id":"2320348175","title":"诺辉健康(06606.HK)的”春天”答案，《大咖面对面》之格隆走进上市公司精彩问答集锦","url":"https://stock-news.laohu8.com/highlight/detail?id=2320348175","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2320348175?lang=zh_CN&edition=full","pubTime":"2023-03-17 10:47","pubTimestamp":1679021265,"startTime":"0","endTime":"0","summary":"寻找春天的第一站，格隆汇将目标聚焦在有着“中国癌症早筛第一股”的诺辉健康。本次活动正值诺辉健康发布2022年年度财报，格隆汇创始人格隆先生与诺辉健康董事长兼CEO朱叶青先生就此展开了一场《解码诺辉年度成绩单背后的增长密码》为主题的圆桌对话，围绕投资者目前关切的问题，从上市公司业绩、商业化成果、创新技术路径、行业成长空间等，展开深入的探讨与展望。赛马是诺辉健康这家公司，棋手就是以朱总为代表的这样一个管理团队。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230317104752826c2d16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230317104752826c2d16&s=b","is_publish_highlight":false},{"id":"2319804602","title":"港股异动 | 诺辉健康-B涨4% 下周一正式摘“B” 获高盛上调目标价至57.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2319804602","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2319804602?lang=zh_CN&edition=full","pubTime":"2023-03-16 10:51","pubTimestamp":1678935113,"startTime":"0","endTime":"0","summary":"格隆汇3月16日丨诺辉健康-B涨4.48%，报34.95港元，总市值160亿港元。诺辉健康-B公布，自今年3月20日(下周一)起，公司的中文及英文股份简称将不再加上标记“B”。此外，公司近日公布，2022年实现营业收入7.7亿元，较2021年同比增长259.5%；实现毛利润6.5亿元，较2021年同比增长318%。基于去年业绩表现，高盛将其今明两年销售额预测上调3%及1%，并将2023至2025年盈利预测上调62%、21%及30%，以反映产品平均售价提升及销售渠道组合优化推动毛利率增长，以及管理和研发费用比率降低所带来的营运效率提升，目标价从55.9港元上调至57.7港元，评级“买入”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230316105302826b9085&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230316105302826b9085&s=b","is_publish_highlight":false},{"id":"2319848855","title":"智通港股解盘 | 受外围影响起起落落 新纳入港股标的需重视","url":"https://stock-news.laohu8.com/highlight/detail?id=2319848855","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2319848855?lang=zh_CN&edition=full","pubTime":"2023-03-15 20:44","pubTimestamp":1678884282,"startTime":"0","endTime":"0","summary":"所有央企及其下属集团公司个股都会成为资金关注的对象。海岬型船运价指数上涨289点或15.9%，至2110点的逾11周高点。对于航运类的上涨，估计和伊朗、沙特达成和解相关，三方合作共盈开发中东市场带来新的预期。注意一下，近期纳入港股通标的的品种都要重视起来。噗噗管为中国首个且唯一获国家药监局批准用于结直肠癌筛查的自检FIT筛查产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/892519.html","is_publish_highlight":false},{"id":"2319281899","title":"高盛：予诺辉健康-B买入评级 目标价升至57.7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2319281899","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2319281899?lang=zh_CN&edition=full","pubTime":"2023-03-15 17:41","pubTimestamp":1678873302,"startTime":"0","endTime":"0","summary":"高盛发布研究报告称，予诺辉健康-B“买入”评级，基于去年业绩表现，将今明两年销售额预测上调3%/1%，并将2023-25年盈利预测上调62%/21%/30%，以反映产品平均售价提升及销售渠道组合优化推动毛利率增长，以及管理和研发费用比率降低所带来的营运效率提升，目标价由55.9港元上调至57.7港元。公司预计今年经营效率将进一步提升，毛利率有望达到85%，销售开支比为60%至65%，而行政费用占比则降至10%-12%，目标今年下半年可实现收支平衡。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2023-03-15/doc-imykxyex3109487.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2023-03-15/doc-imykxyex3109487.shtml","is_publish_highlight":false},{"id":"2319489043","title":"【港股通】诺辉健康(06606)：3月20日起“摘B”","url":"https://stock-news.laohu8.com/highlight/detail?id=2319489043","media":"金吾资讯","top":-1,"share":"https://www.laohu8.com/m/news/2319489043?lang=zh_CN&edition=full","pubTime":"2023-03-15 17:28","pubTimestamp":1678872532,"startTime":"0","endTime":"0","summary":"诺辉健康(06606)公告，自2023年3月20日起，公司的中文及英文股份简称将不再加上标记“B”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230315172918826b2be3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230315172918826b2be3&s=b","is_publish_highlight":false},{"id":"2319890437","title":"诺辉健康-B(06606)：中文及英文股份简称3月20日起不再加上标记“B”","url":"https://stock-news.laohu8.com/highlight/detail?id=2319890437","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2319890437?lang=zh_CN&edition=full","pubTime":"2023-03-15 17:25","pubTimestamp":1678872338,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺辉健康-B(06606)发布公告，自2023年3月20日起，公司的中文及英文股份简称将不再加上标记“B”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/892287.html","is_publish_highlight":false},{"id":"2319899820","title":"*高盛上调诺辉健康-B(06606.HK)目标价至57.7元  评级“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2319899820","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2319899820?lang=zh_CN&edition=full","pubTime":"2023-03-15 15:40","pubTimestamp":1678866000,"startTime":"0","endTime":"0","summary":"(港股报价延迟最少十五分钟。沽空资料截至 2023-03-15 12:25。)AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220113123127127_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220113123127127_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1251821/latest-news/HK6","is_publish_highlight":false},{"id":"2319898807","title":"诺辉健康成功“摘B” ，2022年经调整净亏损1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2319898807","media":"观察者网","top":-1,"share":"https://www.laohu8.com/m/news/2319898807?lang=zh_CN&edition=full","pubTime":"2023-03-15 14:20","pubTimestamp":1678861217,"startTime":"0","endTime":"0","summary":"同期，诺辉健康宣布公司“摘B”申请已成功获批，“摘B”公告将于近日发布。2021年2月18日，诺辉健康于香港联交所成功上市，成为“中国癌症早筛第一股”。截至2022年12月31日，公司现金及特定金融资产结余1为15.7亿元人民币。根据年报数据，2022年诺辉健康销售费用率为70.5%，同比2021年的125.9%下降44%；管理费用率为14.8%，同比2021年的43.7%下降66%。据披露，诺辉健康2022年底完成了1000家医院和医疗机构的准入，进入了这些医院的电子收费目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230315142319826b0d31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230315142319826b0d31&s=b","is_publish_highlight":false},{"id":"2319286587","title":"港股异动|诺辉健康大涨超9%2022年营收大增2.6倍“摘B”申请成功获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2319286587","media":"和讯","top":-1,"share":"https://www.laohu8.com/m/news/2319286587?lang=zh_CN&edition=full","pubTime":"2023-03-15 11:03","pubTimestamp":1678849420,"startTime":"0","endTime":"0","summary":"港股异动|诺辉健康大涨超9%2022年营收大增2.6倍“摘B”申请成功获批：诺辉健康大幅拉升涨超9%，现报32.9港元，总市值150亿港元。公司在2022年全年实现营业收入7.7亿元，较2021年同比增长259.5%；实现毛利润6.5亿元，较2021年同比增长318%；毛利润率从2021年的72.7%攀升至84.5%。同期，公司宣布“摘B”申请已成功获批，将成为港交所第7家去“B”的生物科技公司。“摘B”公告将于近日发布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230315110618826af74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230315110618826af74e&s=b","is_publish_highlight":false},{"id":"2319868316","title":"一图解码：诺辉健康2022年收入增近2.6倍 亏损收窄获批“摘B”","url":"https://stock-news.laohu8.com/highlight/detail?id=2319868316","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2319868316?lang=zh_CN&edition=full","pubTime":"2023-03-15 10:36","pubTimestamp":1678847816,"startTime":"0","endTime":"0","summary":"3月13日盘后，诺辉健康-B(06606.HK)披露了其2022年业绩成绩单。据公告显示，2022年诺辉健康实现收入为7.65亿元人民币(单位下同)，较去年同期增加259.5%；股东应占亏损由上年同期的-30.85亿元大幅收窄至-7923.8万元；毛利率则由上年同期的72.7%提升至2022年的84.5%。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202303_1/4bb2d758-fd35-4a8b-a4d2-e178ff07941e.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202303_1/4bb2d758-fd35-4a8b-a4d2-e178ff07941e.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/64112f4853243c0e604c42b0","is_publish_highlight":false},{"id":"2319852098","title":"港股异动 | 诺辉健康-B(06606)涨9% 22年营收大增约2.6倍、毛利率攀升至84.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2319852098","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2319852098?lang=zh_CN&edition=full","pubTime":"2023-03-15 09:57","pubTimestamp":1678845429,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺辉健康-B(06606)重新活跃，盘初升约9%。22年，公司实现营收同比增长259.5%，毛利率从2021年的72.7%攀升至84.5%。截至发稿，诺辉健康涨9.42%，报33.10港元，成交额0.33亿港元。3月13日晚，诺辉健康发布2022年年度业绩。期内实现营业收入接近7.7亿元，同比增长259.5%；实现毛利润6.5亿元，同比增长318%；毛利润率从2021年的72.7%攀升至84.5%。诺辉健康首席财务官高煜表示，公司对2023年业绩的预期目标是接近盈亏平衡，2024年则是达到盈亏平衡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/891999.html","is_publish_highlight":false},{"id":"2319854123","title":"快讯：生物医药B类股集体走强 博安生物涨近70%诺辉健康涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2319854123","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2319854123?lang=zh_CN&edition=full","pubTime":"2023-03-15 09:39","pubTimestamp":1678844374,"startTime":"0","endTime":"0","summary":"3月15日消息，生物医药B类股集体走强，博安生物涨近70%，诺辉健康涨超7%，科济药业涨6.59%，荣昌生物涨5.88%，再鼎医药涨4.84%。\n\n\n炒股开户享福利，送投顾服务60天体验权，一对一指导服务！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-03-15/doc-imykxiih2386313.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2023-03-15/doc-imykxiih2386313.shtml","is_publish_highlight":false},{"id":"2319590788","title":"诺辉健康（06606.HK）：成长性持续释放，战略加持下成长路径清晰","url":"https://stock-news.laohu8.com/highlight/detail?id=2319590788","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2319590788?lang=zh_CN&edition=full","pubTime":"2023-03-15 09:09","pubTimestamp":1678842566,"startTime":"0","endTime":"0","summary":"随着疫情阴霾消散，线下市场活动恢复，医药行业的景气度升温，诺辉健康的增长空间还将有望持续释放...","market":"hk","thumbnail":"https://img7.gelonghui.com/column/7.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/7.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/586359","is_publish_highlight":false},{"id":"2319000424","title":"诺辉健康2022年营收同比增长2.6倍 称2024年实现盈亏平衡","url":"https://stock-news.laohu8.com/highlight/detail?id=2319000424","media":"经济观察网","top":-1,"share":"https://www.laohu8.com/m/news/2319000424?lang=zh_CN&edition=full","pubTime":"2023-03-14 21:29","pubTimestamp":1678800540,"startTime":"0","endTime":"0","summary":"3月13日，癌症早筛生物科技公司诺辉健康公布了2022年全年业绩，营收同比增长约2.6倍，亏损幅度从2021年的2.6亿元收窄至约1亿元。从收入贡献来看，常卫清贡献了诺辉健康2022年几乎一半的营业收入，截至12月31日，常卫清中国内地实现收入3.6亿元，同比增长266.2%；全年实现发货量约80.6万单位，同比增长21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023031421355982bb3a6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023031421355982bb3a6f&s=b","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0254},{"period":"1month","weight":0.025},{"period":"3month","weight":0.8025},{"period":"6month","weight":1.2027},{"period":"1year","weight":0.4009},{"period":"ytd","weight":0.7472}],"websiteUrl":null,"compareEarnings":[{"period":"1week","weight":0.0298},{"period":"1month","weight":-0.0221},{"period":"3month","weight":-0.0013},{"period":"6month","weight":0.1343},{"period":"1year","weight":-0.0858},{"period":"ytd","weight":-0.0108}],"name":"诺辉健康","description":"New Horizon Health Ltd是一家主要从事结直肠癌、胃癌及宫颈癌筛查产品的研发、临床开发、测试营运及商业化业务的中国投资控股公司。该公司通过其自有网络、合同销售组织（CSO）以及由医疗诊所营运的网上销售或电子平台向客户销售常卫清、噗噗管及其他产品。该公司的幽幽管（一种基于粪便的自检胃癌筛查测试）和宫证清（一种非侵入性尿液宫颈癌家用筛查测试）产品处于开发阶段。","exchange":"SEHK","nameEN":"NH HEALTH","compareStock":{"symbol":"HSI","name":"恒生指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.12.1","shortVersion":"4.12.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺辉健康(06606)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺辉健康(06606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺辉健康,06606,诺辉健康股票,诺辉健康股票老虎,诺辉健康股票老虎国际,诺辉健康行情,诺辉健康股票行情,诺辉健康股价,诺辉健康股市,诺辉健康股票价格,诺辉健康股票交易,诺辉健康股票购买,诺辉健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺辉健康(06606)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺辉健康(06606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}